EZH2 and triple-negative breast carcinoma: Although little is known about the mechanistic aspects of EZH2 activity in GBM, the inhibition of EZH2 expression by miR-340 in triple negative breast cancer has led to decreased levels of miR-21, revealing a key miRNA network pathway [59].